healthcare
HeadlinesPope Francis Remains Critical and Has 'slight' Kidney Issue, Vatican Says
HeadlinesAustralia Government Pledges A$8.5 Billion to Healthcare as Election Looms
HeadlinesChinese Researchers Find Bat Virus Enters Human Cells via Same Pathway as Covid
FinanceAstraZeneca Boosts China Presence With FibroGen's Anemia Drug in $160 Million Deal
Vatican Cancels Pope Francis' Weekend Engagements - Statement
Date: February 18, 2025
VATICAN CITY (Reuters) - Pope Francis will not take part in this weekend's Holy Year events because of his continued ill health, the Vatican said on Tuesday. The 88-year-old pontiff has been suffering...
Trump's Aid Cuts Stop South African Hiv Vaccine Trials in Their Tracks
Date: February 18, 2025
By Nellie Peyton JOHANNESBURG (Reuters) - South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the...
After Shocking Pelicot Crimes, French Surgeon to Face Trial in Child Sex Abuse Case
Date: February 17, 2025
By Juliette Jabkhiro NANTES, France (Reuters) - When police in western France searched surgeon Joel Le Scouarnec's home after he raped his 6-year-old neighbour in 2017, they found a cache of sex dolls...
Europe's Stoxx 600 Closes Higher on Healthcare Boost; Auto Stocks Slide
Date: February 5, 2025
(Reuters) - European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk's strong earnings were countered by losses in technology stocks....
Wegovy Sales Double to Boost Novo Nordisk's Fourth Quarter as Growth Set to Slow
Date: February 5, 2025
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) - Weight-loss and diabetes drugmaker Novo Nordisk on Wednesday posted fourth-quarter operating profit above expectations as it forecast...
Europe to Review Safety Data for Eisai-Biogen Alzheimer's Drug
Date: January 31, 2025
(Reuters) - The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's Alzheimer's drug Leqembi, the agency said on Friday. The safety...